Literature DB >> 19880524

Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones.

Jason E Fish1, Matthew S Yan, Charles C Matouk, Rosanne St Bernard, J J David Ho, J J David Ho, Anna Gavryushova, Deepak Srivastava, Philip A Marsden.   

Abstract

Hypoxia elicits endothelial dysfunction, in part, through reduced expression of endothelial nitric-oxide synthase (eNOS). Here we present evidence that hypoxia causes a rapid decrease in the transcription of the eNOS/NOS3 gene, accompanied by decreased acetylation and lysine 4 (histone H3) methylation of eNOS proximal promoter histones. Surprisingly, we demonstrate that histones are rapidly evicted from the eNOS proximal promoter during hypoxia. We also demonstrate endothelium-specific H2A.Z incorporation at the eNOS promoter and find that H2A.Z is also evicted by hypoxic stimulation. After longer durations of hypoxia, histones are reincorporated at the eNOS promoter, but these histones lack substantial histone acetylation. Additionally, we identify a key role for the chromatin remodeler, BRG1, in re-establishing eNOS expression following reoxygenation of hypoxic cells. We posit that post-translational histone modifications are required to maintain constitutive eNOS transcriptional activity and that histone eviction rapidly resets histone marks and is a proximal event in the hypoxic repression of eNOS. Although nucleosome eviction has been reported in models of transcriptional activation, the observation that eviction can also accompany transcriptional repression in hypoxic mammalian cells argues that eviction may be broadly relevant to both positive and negative changes in transcription.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880524      PMCID: PMC2801283          DOI: 10.1074/jbc.M109.067868

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  83 in total

Review 1.  Coupling RNA polymerase II transcription with pre-mRNA processing.

Authors:  D Bentley
Journal:  Curr Opin Cell Biol       Date:  1999-06       Impact factor: 8.382

2.  Histone dynamics on the interleukin-2 gene in response to T-cell activation.

Authors:  Xinxin Chen; Jun Wang; Donna Woltring; Steve Gerondakis; M Frances Shannon
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  The SWI/SNF complex creates loop domains in DNA and polynucleosome arrays and can disrupt DNA-histone contacts within these domains.

Authors:  D P Bazett-Jones; J Côté; C C Landel; C L Peterson; J L Workman
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 4.  Hypoxic pulmonary vasoconstriction.

Authors:  Rohit Moudgil; Evangelos D Michelakis; Stephen L Archer
Journal:  J Appl Physiol (1985)       Date:  2005-01

5.  Human SWI-SNF component BRG1 represses transcription of the c-fos gene.

Authors:  D J Murphy; S Hardy; D A Engel
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

6.  Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels.

Authors:  J N Wilcox; R R Subramanian; C L Sundell; W R Tracey; J S Pollock; D G Harrison; P A Marsden
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

7.  An essential role for p300/CBP in the cellular response to hypoxia.

Authors:  Z Arany; L E Huang; R Eckner; S Bhattacharya; C Jiang; M A Goldberg; H F Bunn; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

8.  Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing.

Authors:  K N Harikrishnan; Maggie Z Chow; Emma K Baker; Sharmistha Pal; Sahar Bassal; Daniella Brasacchio; Li Wang; Jeff M Craig; Peter L Jones; Saïd Sif; Assam El-Osta
Journal:  Nat Genet       Date:  2005-02-06       Impact factor: 38.330

9.  The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia.

Authors:  K A Fagan; B W Fouty; R C Tyler; K G Morris; L K Hepler; K Sato; T D LeCras; S H Abman; H D Weinberger; P L Huang; I F McMurtry; D M Rodman
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Characterization of the human endothelial nitric-oxide synthase promoter.

Authors:  F Karantzoulis-Fegaras; H Antoniou; S L Lai; G Kulkarni; C D'Abreo; G K Wong; T L Miller; Y Chan; J Atkins; Y Wang; P A Marsden
Journal:  J Biol Chem       Date:  1999-01-29       Impact factor: 5.157

View more
  56 in total

1.  Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism.

Authors:  Andrew Advani; Qingling Huang; Kerri Thai; Suzanne L Advani; Kathryn E White; Darren J Kelly; Darren A Yuen; Kim A Connelly; Philip A Marsden; Richard E Gilbert
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Chromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Transl Stroke Res       Date:  2011-03-01       Impact factor: 6.829

3.  Endothelial cell-specific expression of roundabout 4 is regulated by differential DNA methylation of the proximal promoter.

Authors:  Yoshiaki Okada; Nobuaki Funahashi; Toru Tanaka; Yuji Nishiyama; Lei Yuan; Keisuke Shirakura; Alexis S Turjman; Yoshihiro Kano; Hiroki Naruse; Ayano Suzuki; Miki Sakai; Jiang Zhixia; Kenji Kitajima; Kenji Ishimoto; Nobumasa Hino; Masuo Kondoh; Yohei Mukai; Shinsaku Nakagawa; Guillermo García-Cardeña; William C Aird; Takefumi Doi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-22       Impact factor: 8.311

4.  Voluntary Physical Exercise Induces Expression and Epigenetic Remodeling of VegfA in the Rat Hippocampus.

Authors:  Christina A E Sølvsten; Frank de Paoli; Jane H Christensen; Anders L Nielsen
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

5.  Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH.

Authors:  Jahidur Rashid; Ahmad Alobaida; Taslim A Al-Hilal; Samia Hammouda; Ivan F McMurtry; Eva Nozik-Grayck; Kurt R Stenmark; Fakhrul Ahsan
Journal:  J Control Release       Date:  2018-04-30       Impact factor: 9.776

6.  Endothelial dysfunction in children with obstructive sleep apnea is associated with epigenetic changes in the eNOS gene.

Authors:  Leila Kheirandish-Gozal; Abdelnaby Khalyfa; David Gozal; Rakesh Bhattacharjee; Yang Wang
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

7.  Drosophila genome-wide RNAi screen identifies multiple regulators of HIF-dependent transcription in hypoxia.

Authors:  Andrés Dekanty; Nuria M Romero; Agustina P Bertolin; María G Thomas; Claudia C Leishman; Joel I Perez-Perri; Graciela L Boccaccio; Pablo Wappner
Journal:  PLoS Genet       Date:  2010-06-24       Impact factor: 5.917

Review 8.  The role of redox signaling in epigenetics and cardiovascular disease.

Authors:  Gene H Kim; John J Ryan; Stephen L Archer
Journal:  Antioxid Redox Signal       Date:  2013-03-12       Impact factor: 8.401

Review 9.  Using advanced noninvasive imaging techniques to probe the links between regional coronary artery endothelial dysfunction and atherosclerosis.

Authors:  Micaela Iantorno; Robert G Weiss
Journal:  Trends Cardiovasc Med       Date:  2013-10-16       Impact factor: 6.677

10.  Active stabilization of human endothelial nitric oxide synthase mRNA by hnRNP E1 protects against antisense RNA and microRNAs.

Authors:  J J David Ho; G Brett Robb; Sharon C Tai; Paul J Turgeon; Imtiaz A Mawji; H S Jeffrey Man; Philip A Marsden
Journal:  Mol Cell Biol       Date:  2013-03-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.